Tag: Therapeutics
Navigating the Future of Medicine: Eli Lilly’s Collaboration with Seamless Therapeutics Unveiled
Summary: 1. Eli Lilly has seen significant success in the GLP-1 space, driving a substantial increase in its…
The Surge of Vera Therapeutics Stock: What’s Behind the Zoom?
Summary: 1. Vera Therapeutics has submitted a biologics license application for its leading investigational drug, atacicept, targeting IgA…
The Downfall of Corcept Therapeutics: A 50% Plunge Explained
Summary: 1. Corcept Therapeutics received a regulatory rejection from the FDA for its hypertension medication, leading to a…
Dyne Therapeutics Surges in Stock Price Today: Here’s Why
Summary: 1. Dyne Therapeutics reported significant progress with its investigational drug for Duchenne muscular dystrophy. 2. The drug…
The Surprising Success of Vera Therapeutics: A Stock Soars
Summary: 1. Vera Therapeutics stock saw a significant increase after a bullish note from Cantor Fitzgerald's analyst. 2.…
The Surge of Nektar Therapeutics: Stock Skyrockets Over 15%
Summary: 1. Nektar Therapeutics' pipeline drug, rezpegaldesleukin, has shown promising results in a phase 2b study for atopic…
Exploring the Surge: The Rise of Viking Therapeutics Stock
Summary: Healthcare companies are actively developing obesity drugs, with Viking Therapeutics seeing a 4% stock price increase due…
The Rise of Nektar Therapeutics: A 6% Surge in Stock Performance
Summary: 1. Nektar Therapeutics reported strong quarterly earnings with a 6% increase in share price, outperforming the S&P…
Paradigm Therapeutics Secures Increased Funding from Eshelman Ventures
Summary: Paradigm Therapeutics receives an additional $12.6M investment from Eshelman Ventures, bringing the total investment in 2025 to…
Vima Therapeutics Secures $60 Million in Series A Investment Round
Summary: Vima Therapeutics, a biotechnology company based in Cambridge, MA, secured $60M in Series A funding led by…
Grin Therapeutics Secures $140M in Series D Funding Round
Summary: Grin Therapeutics, Inc. secured a $140 million Series D financing, with a significant investment from Angelini Pharma…
Remedy Plan Therapeutics Secures $18M in Funding for Innovative Treatments
Summary: Remedy Plan Therapeutics, a pharmaceutical company in Gaithersburg, MD, secured $18M in funding for developing new NAMPT…